首页> 外文期刊>Mutagenesis >Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
【24h】

Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.

机译:他莫昔芬和α-羟基他莫昔芬在大鼠中形成DNA加合物的器官特异性:对于了解他莫昔芬致癌性机理和人类风险评估的意义。

获取原文
获取原文并翻译 | 示例
           

摘要

Tamoxifen is an anti-oestrogen widely used in the adjuvant therapy of breast cancer and is also used as a prophylactic to prevent the disease in high-risk women. An increased risk of endometrial cancer has been observed in both settings. In rats, tamoxifen potently induces liver carcinomas and also induces uterine tumours when given neonatally. It forms DNA adducts in rat liver via the formation of alpha-hydroxytamoxifen, the ultimately reactive form being generated by sulfotransferase. In order to investigate the formation of tamoxifen-derived DNA adducts in other rat tissues, female Fischer F344 or Sprague-Dawley rats were treated with tamoxifen or alpha-hydroxytamoxifen by gavage or by intraperitoneal injection, daily for 1, 4 or 7 days, and DNA adducts were detected by (32)P-postlabelling analysis. Tamoxifen formed DNA adducts in the liver but not in other tissues (uterus, stomach, kidney, spleen and colon). alpha-Hydroxytamoxifen also formed adducts at high levels in liver, but with the exception of single animals (1/8) in which a low level of adducts was detected in the stomach in one case, and in the kidney in the other; it also did not give rise to adducts in other tissues. The results suggest that tamoxifen is a genotoxic carcinogen in rat liver, but a non-genotoxic carcinogen in rat uterus, making it, uniquely, a carcinogen with more than one mechanism of action. Mutagenicity experiments conducted in Salmonella typhimurium strains expressing bacterial or human N,O-acetyltransferase did not provide evidence that either alpha-hydroxytamoxifen or alpha-hydroxy-N-desmethyltamoxifen undergoes metabolic activation by acetylation. The confinement of ST2A2, the isozyme of hydroxysteroid sulfotransferase that can activate the compounds, mainly to rat liver is the possible reason for the formation of ducts in the liver but not in other organs of the rat.
机译:他莫昔芬是一种抗雌激素药物,广泛用于乳腺癌的辅助治疗,还被用作预防高危女性疾病的预防剂。在两种情况下都观察到子宫内膜癌的风险增加。在大鼠中,他莫昔芬在新生儿时有效诱导肝癌,还诱导子宫肿瘤。它通过形成α-羟基他莫昔芬在大鼠肝脏中形成DNA加合物,而最终的反应形式是由磺基转移酶产生的。为了研究他莫昔芬衍生的DNA加合物在其他大鼠组织中的形成,每天对雌性Fischer F344或Sprague-Dawley大鼠进行灌胃或腹膜内注射他莫昔芬或α-羟基他莫昔芬治疗,持续1、4或7天,以及通过(32)P后标记分析检测DNA加合物。他莫昔芬在肝脏中形成DNA加合物,但在其他组织(子宫,胃,肾,脾和结肠)中不形成。 α-羟基他莫昔芬在肝脏中也形成高水平的加合物,但单只动物(1/8)除外,其中在一种情况下在胃中检测到低水平的加合物,在另一例中在肾脏中检测到低水平的加合物。它也没有在其他组织中引起加合物。结果表明他莫昔芬是大鼠肝脏中的一种遗传毒性致癌物,但在大鼠子宫中是一种非遗传毒性致癌物,因此使其独特地成为一种具有多种作用机理的致癌物。在表达细菌或人N,O-乙酰基转移酶的鼠伤寒沙门氏菌菌株中进行的致突变性实验没有提供证据表明α-羟基他莫昔芬或α-羟基-N-去甲基他莫昔芬通过乙酰化而发生代谢活化。 ST2A2(可以激活化合物的羟基类固醇磺基转移酶的同功酶)的封闭主要在大鼠肝脏中,这可能是在肝脏中形成导管但在大鼠其他器官中未形成导管的可能原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号